MDNZ is seeking support for the Vision for 2020 Campaign, a new initiative that will save New Zealander's sight. Over the next 3 years, MDNZ aims to make significant inroads into reducing the incidence and impact of macular degeneration.

The Chair of MDNZ's Medical Committee, Dr Andrew Thompson, comments that the trial results are encouraging but the reality of this as a routine treatment is still many years away. 

After a number of years consulting with the sector regarding a model of care for eye health, the Ministry of Health commissioned Ernst and Young (EY) to compile a report titled "Age-related Macular Degeneration - Model of Care assessment and recommendations".  The report was finalised in August 2017 and covers 3 broad areas:

Listen to Ophthalmologist, Dr Andrew Thompson, speak at the recent Tauranga Awareness & Education seminar.

One News interviews Dr Dianne Sharp on the report which Macular Degeneration NZ commissioned from Deloitte Access Economics on the socioeconomic cost of macular degeneration in New Zealand.